Health
Study finds significant variation in biomarker test utilization and treatment for non–small-cell lung cancer – News-Medical.Net
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis…
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis of non-small-cell lung cancer (NSCLC). In a new study in TheJournal of Molecular Diagnosis, published by Elsevier, investigators provide for the first time a complete overview of biomarker testing, spanning multiple treatment lines, in a single cohort of patients.
Using exploratory data analysis and process-mining techniques in a real-world…
-
Noosa News24 hours agoHusband charged after beloved Brisbane nurse Carra Luke allegedly stabbed to death in Taigum home
-
Noosa News23 hours agoRallies under way as nationwide support for Palestine surges
-
General23 hours agoTens of thousands protest in nationwide action against war in Gaza
-
General22 hours agoAuthorities say charged man used false name to escape from Perth court